C

Cutting Edge Research Group | Oklahoma City, OK

Research site
(Unclaimed)
Location
6613 North. Meridian Avenue, Oklahoma City, Oklahoma, United States of America
Site insights

Top conditions

Depression (11 trials)

Attention Deficit Disorder with Hyperactivity (10 trials)

Major Depressive Disorder (10 trials)

Depressive Disorder (10 trials)

Hyperkinesis (9 trials)

Top treatments

Lurasidone
Brexpiprazole
Dasotraline
Cariprazine
Ziprasidone
Hydrocodone Bitartrate
Divalproex
Lithium
Vilazodone
Balovaptan

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

5 of 57
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)

The main aim of this study is learn more about long-term TAK-503 treatment in children and teenagers with ADHD for whom earlier stimulant treatment d...

Enrolling
Attention Deficit Hyperactivity Disorder
Drug: Guanfacine hydrochloride (TAK-503)
Other: Placebo

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling
Bipolar I Disorder
Depression
Drug: Placebo
Drug: Cariprazine

This study is open to adults with schizophrenia. Schizophrenia can affect the way a person thinks, their memory and their mental functioning. Example...

Enrolling
Schizophrenia
Drug: Placebo
Drug: iclepertin

The purpose of this study is to evaluate the long-term safety and tolerability of cariprazine in the treatment of pediatric participants with schizop...

Enrolling
Bipolar I Disorder
Schizophrenia
Drug: Cariprazine Flexible Dose

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and so...

Active, not recruiting
Episodic Migraine
Drug: BOTOX
Drug: Placebo

Trial sponsors

S

Sumitomo Pharma America, Inc. (13 trials)

Pfizer logo

Pfizer (7 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems